Janus Living JAN 深 沪
已收盘 08-21 16:00:00 美东时间
30.71
+0.120
+0.39%
华盛通- 最 高31.005
- 今 开30.83
- 成交量 81.52万股
- 最 低 30.60
- 昨 收 30.59
- 总市值 89.64亿
- 52周最高 32.7825
- 市盈率 静 --
- 换手率 0.28%
- 52周最低 22.5051
- 委 比 2.04%
- 总股本 2.92亿
- 历史最高 32.7825
- 量 比 0.64
- 振 幅 1.32%
- 历史最低 22.5051
- 每 手 1
- 风险率 2.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅167.3%！HC Wainwright上调Tango Therapeutics目标价至68美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Tango Therapeutics"买入"评级，目标价从66美元升至68美元；康托·菲茨杰拉德：维持Duos Technologies Group"超配"评级，目标价从26美元升至27美元
08-19 08:37
Morgan Stanley Maintains Overweight on Janus Living, Raises Price Target to $31
Morgan Stanley analyst Ronald Kamdem maintains Janus Living (NYSE:JAN) with a Overweight and raises the price target from $28 to $31.
08-18 22:24
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
Cantor Fitzgerald Maintains Overweight on Janus Living, Raises Price Target to $34
Cantor Fitzgerald analyst Richard Anderson maintains Janus Living (NYSE:JAN) with a Overweight and raises the price target from $30 to $34.
08-06 20:22
Janus Living Boosts Outlook on Debt-Free Growth
Janus Living, Inc. Class A (($JAN)) has held its Q2 earnings call. Read on for ...
08-06 08:24
Janus Living Raises FY2026 FFO Guidance from $0.93-$0.97 to $0.95-$0.98 vs $0.96 Est
Janus Living (NYSE:JAN) raises FY2026 FFO guidance from $0.93-$0.97 to $0.95-$0.98 vs $0.96 analyst estimate..
08-05 04:25
美股大行评级 | 潜在涨幅284.62%！Annexon获Needham上调目标价至25美元；多家大行上调美国银行目标价
今日重点评级关注：Needham：维持Annexon"买入"评级，目标价从11美元升至25美元；Benchmark：维持Prenetics Global"买入"评级，目标价从30美元升至40美元
07-16 18:55
Wells Fargo Maintains Overweight on Janus Living, Raises Price Target to $33
Wells Fargo analyst John Kilichowski maintains Janus Living (NYSE:JAN) with a Overweight and raises the price target from $31 to $33.
07-15 19:33
Janus Living, Inc. declares $0.0475 dividend
Janus Living, Inc. (JAN) declares $0.0475/share monthly dividend. Forward yield 1.94% Payable July 29; for shareholders of record July 17; ex-div July 17. Payable Aug 26; for shareholders of record Au...
07-09 04:31
